1. Pink Sheet

US FDA Exploring Furlough Possibility If User Fee Bill Not Enacted In Time

 
• By Derrick Gingery

Furloughs would allow affected FDA staff to remain employed, while a layoffs would require affected workers to be rehired.

Furlough stamp
Furloughing employees could be more advantageous for the FDA than official layoffs if the user fee programs are not renewed in time. • Source: Shutterstock

The US Food and Drug Administration may try to classify a late user fee reauthorization as a temporary work stoppage rather than a permanent separation for thousands of its employees.

Officials at the US Food and Drug Administration are exploring the possibility of furloughing employees instead of laying them off should Congress fail to pass a user fee reauthorization package...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from User Fees

More from Pathways & Standards